RUTH WILSON: Open Payments
NPI 1457415705 · LAGRANGE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,775 in 81 payments from 13 companies in 2025. Trend: 2023 $1,696 · 2024 $1,958 · 2025 $1,775
Food & beverage: $1,775
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $937 |
| Amgen Inc. | 16 | $288 |
| UCB, Inc. | 7 | $193 |
| Lilly USA, LLC | 4 | $98 |
| Novartis Pharmaceuticals Corporation | 2 | $55 |
| Alexion Pharmaceuticals, Inc. | 2 | $54 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| GENZYME CORPORATION | 1 | $25 |
| SOBI, INC | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
Products named: RINVOQ, SKYRIZI, Bimzelx, EVENITY, TALTZ, TAVNEOS, STRENSIQ, OTEZLA.
Industry payments across IN — which companies pay providers there.
